Clinical Trial: A non-randomized, open-label, parallel-controlled pharmacokinetic and safety study of XY0206 tablets in participants with mild to moderate hepatic insufficiency and healthy participants. (China)

China, Aug. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A non-randomized, open-label, parallel-controlled pharmacokinetic and safety study of XY0206 tablets in participants with mild to moderate hepatic insufficiency and healthy participants.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129971

Registration Time: 2026/08/12

Type: Interventional study

Primary Sponsor: Shulan (Quzhou) Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=288876

Published by HT Digital Content Services with permission from Health Daily Digest....